← Evidence map

ReviewCancers2026

Evolving Systemic Therapy for Prostate Cancer: Pivotal Clinical Trials, Biomarker-Driven Combinations, and Practical Sequencing in the ARSI-PARP-Radioligand Era.

Takatoshi Somoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Evolving Systemic Therapy for Prostate Cancer: Pivotal Clinical Trials, Biomarker-Driven Combinations, and Practical Sequencing in the ARSI-PARP-Radioligand Era. | Socratic